Bureau of Medical Services (U.S. Department of State)

Myths about will power and moral weakness keep people with opioid use disorder from receiving effective medications like methadone, buprenorphine and naltrexone

Retrieved on: 
Thursday, July 13, 2023

Methadone and buprenorphine prevent intense cravings and other symptoms of withdrawal, while naltrexone works by blocking the effects of opioids.

Key Points: 
  • Methadone and buprenorphine prevent intense cravings and other symptoms of withdrawal, while naltrexone works by blocking the effects of opioids.
  • We asked what they thought about using medication to treat opioid use disorder.
  • Across all four groups, we heard three myths about using medication for opioid use disorder.

Medication isn’t trading one drug for another

    • Many of our participants expressed the belief that using medication is the same as using opioids to get high.
    • This misperception is likely rooted in the outdated idea that recovery is defined by total abstinence from all substances, except perhaps caffeine and nicotine.

Medication is an important part of long-term recovery

    • A community member we spoke with said, “It’s a way of weaning them off everything.
    • Guidelines from the U.S. Department of Health and Human Services discourage rapid tapers and affirm that long-term use is the best way to prevent relapse, overdose and death.

Long-term treatment counts as success

    • Many of our study participants voiced the belief that long-term use of medication means the treatment did not work.
    • Just as those with high blood pressure or diabetes may need to remain on medications for the long term, so might some people with opioid use disorder.
    • Keeping people in treatment and alive through use of medications is treatment success, not failure.
    • The latest data from the U.S. Centers for Disease Control and Prevention estimates nearly 83,000 deaths in 2022 involved opioids.

BERGER MONTAGUE ANNOUNCES LAUNCH OF FULL-SERVICE INTELLECTUAL PROPERTY PRACTICE

Retrieved on: 
Wednesday, June 21, 2023

PHILADELPHIA, June 21, 2023 /PRNewswire/ -- Berger Montague is pleased to announce that effective today, it has added one of the leading intellectual property groups in the country to represent clients worldwide in all facets of intellectual property law. In doing so, Berger Montague, an award-winning national complex litigation firm, will fill a critical need in the marketplace for a full-service IP firm that can represent clients in all their IP legal needs on a cost-effective basis. The new practice area is opening with a group of seven senior IP lawyers plus staff, who have joined Berger Montague after leaving a large defense-side law firm in Philadelphia.

Key Points: 
  • By retaining Berger Montague for their IP legal needs, clients will benefit from more personalized, boutique, and bespoke service.
  • Berger Montague Chairman Eric L. Cramer stated, "We're thrilled to be building out an intellectual property and patent infringement litigation practice at Berger Montague, and there isn't a better group of attorneys than Alfred's team to usher the firm into this area of law.
  • Mr. Haleva focuses his practice on intellectual property litigation, as well as patent and trademark preparation and prosecution in various industries.
  • Berger Montague encourages U.S. and international businesses and individuals to contact the firm for more information concerning representation in intellectual property matters, including patents, trademarks, copyrights, trade secrets, and domain names.

ZOLEO Inc. Launches Revolutionary Medical Assist Service

Retrieved on: 
Wednesday, June 7, 2023

TORONTO, June 07, 2023 (GLOBE NEWSWIRE) -- ZOLEO Inc., the esteemed global messaging solutions company, has once again raised the bar by introducing Medical Assist.

Key Points: 
  • TORONTO, June 07, 2023 (GLOBE NEWSWIRE) -- ZOLEO Inc., the esteemed global messaging solutions company, has once again raised the bar by introducing Medical Assist.
  • This trailblazing feature establishes the industry’s first non-emergency medical assistance chat service, available 24/7 to users of its ZOLEO global satellite messaging solution.
  • With a simple tap of the Medical Assist feature in the ZOLEO mobile app, users now have direct access to medical professionals for non-emergency help, anywhere in the world.
  • Medical Assist inquiries are sent directly to Global Rescue, the emergency response coordination partner for ZOLEO, along with the user’s GPS coordinates.

Northwell Direct to Provide Telehealth Services to U.S. Department of State

Retrieved on: 
Wednesday, May 31, 2023

Northwell Direct today announced that it has been selected as the subcontractor on a U.S. Department of State (DOS) contract to provide telehealth consult services to DOS medical providers serving U.S. Government (USG) employees and family members posted overseas.

Key Points: 
  • Northwell Direct today announced that it has been selected as the subcontractor on a U.S. Department of State (DOS) contract to provide telehealth consult services to DOS medical providers serving U.S. Government (USG) employees and family members posted overseas.
  • View the full release here: https://www.businesswire.com/news/home/20230531005777/en/
    Leveraging Northwell Health ’s extensive network of specialists, Northwell Direct will provide consultation services to DOS that will assist its medical staff around the world.
  • “Telemedicine is a unique area of opportunity for Northwell Direct to provide support and expertise to the Department of State,” said Jonathan Berkowitz, MD, medical director of center emergency medical services at Northwell Health.
  • “Northwell Direct is proud to be working with the United States Department of State and doing our part to ensure that the employees and family members who serve our country have access to the highest quality health care services while serving abroad,” said Nick Stefanizzi , Chief Executive Officer of Northwell Direct.

TorchStone Welcomes Personal Protection Expert Christopher Keenan to Deliver Proactive Private Client Security Services

Retrieved on: 
Tuesday, April 25, 2023

LOS ANGELES, April 25, 2023 /PRNewswire-PRWeb/ -- TorchStone Global, a premiere risk mitigation and security firm, announced that Christopher Keenan has joined the team as Vice President. Christopher brings over 25 years of experience in worldwide security operations, management, and leadership, including 18 years as a Special Agent with the U.S. Department of State's Diplomatic Security Service.

Key Points: 
  • LOS ANGELES, April 25, 2023 /PRNewswire-PRWeb/ -- TorchStone Global, a premiere risk mitigation and security firm, announced that Christopher Keenan has joined the team as Vice President.
  • He will provide executive protection, event and venue security coordination, threat and vulnerability assessments, risk mitigation, secure travel operations and logistics, internal program audits, and training.
  • TorchStone Global is a leader in global risk mitigation and security, delivering proactive guidance and protection for prominent clients around the globe.
  • Combining state-of-the-art proactive strategies with experienced professionals and cutting-edge technologies, TorchStone provides discreet, relationship-based security solutions for their clients around the globe.

Feds for Med Freedom Files Suit Against U.S. State Department for Vaccine Mandate, Religious Discrimination

Retrieved on: 
Wednesday, March 8, 2023

It asks the court to declare the State Department's acts unlawful and discriminatory and to award appropriate monetary damages for injuries suffered.

Key Points: 
  • It asks the court to declare the State Department's acts unlawful and discriminatory and to award appropriate monetary damages for injuries suffered.
  • Feds for Medical Freedom is suing the State Department for discriminating against unvaccinated employees.
  • If successful, this lawsuit would be a landmark win in the effort to hold the government accountable for its discriminatory, unconstitutional, and anti-scientific COVID vaccine mandate.
  • Our goals are to block the enforcement of this mandate, hold bad actors accountable and compensate those who have been injured by unlawful discrimination."

CGI Federal announces extension of 10-year partnership with U.S. State Department in support of Consular Affairs services in India

Retrieved on: 
Thursday, March 2, 2023

FAIRFAX, Va., March 2, 2023 /PRNewswire/ - CGI Federal, the wholly-owned U.S. operating subsidiary of CGI Inc. (NYSE: GIB) (TSX: GIB.A), announced today that it will continue to support consular services for the U.S. Department of State's Bureau of Consular Affairs in the Republic of India.

Key Points: 
  • FAIRFAX, Va., March 2, 2023 /PRNewswire/ - CGI Federal, the wholly-owned U.S. operating subsidiary of CGI Inc. (NYSE: GIB) (TSX: GIB.A), announced today that it will continue to support consular services for the U.S. Department of State's Bureau of Consular Affairs in the Republic of India.
  • The services will be delivered under a new, 10-year task order awarded in January 2023 under the Global Support Strategy for Overseas Consular Support Services 2.0 (GSS 2.0) contract.
  • Specifically, CGI Federal will leverage its proven CGI Atlas360 solution to provide critical on-site processing support for consular services.
  • Configured to meet the needs of U.S. consulates, CGI Federal will continue to leverage its CGI Atlas360 solution in India.

Global Infertility Drugs Market Report 2022: Factors Increasing Infertility Cases in Men and Women Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 25, 2023

The Global Infertility Drugs Market size is expected to reach $4.8 billion by 2028, rising at a market growth of 6.2 % CAGR during the forecast period.

Key Points: 
  • The Global Infertility Drugs Market size is expected to reach $4.8 billion by 2028, rising at a market growth of 6.2 % CAGR during the forecast period.
  • The growing prevalence of infertility or the difficulty of bringing a baby to term throughout the world is what fuels the market for infertility medications.
  • Based on end-user, the infertility drugs Market is divided into Men and Women.
  • Based on distribution channel, the Infertility Drugs Market is divided into Hospital Pharmacy, Specialty & Retail Pharmacy, and Online Pharmacy.

Global Infertility Drugs Market Report 2022: Sector to Reach $4.8 Billion by 2028 at a 6.2% CAGR

Retrieved on: 
Thursday, January 26, 2023

The Global Infertility Drugs Market size is expected to reach $4.8 billion by 2028, rising at a market growth of 6.2 % CAGR during the forecast period.

Key Points: 
  • The Global Infertility Drugs Market size is expected to reach $4.8 billion by 2028, rising at a market growth of 6.2 % CAGR during the forecast period.
  • The growing prevalence of infertility or the difficulty of bringing a baby to term throughout the world is what fuels the market for infertility medications.
  • Based on distribution channel, the Infertility Drugs Market is divided into Hospital Pharmacy, Specialty & Retail Pharmacy, and Online Pharmacy.
  • Based on drug class, the infertility drugs market is classified into Gonadotropins, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs), Dopamine Agonists, and Others.

Envision Healthcare Releases New White Paper Addressing Social Determinants of Health, Promoting Health Equity

Retrieved on: 
Monday, December 19, 2022

Envision Healthcare, a leading national medical group, is continuing work to improve health equity by addressing social determinants of health (SDOH).

Key Points: 
  • Envision Healthcare, a leading national medical group, is continuing work to improve health equity by addressing social determinants of health (SDOH).
  • The medical group’s new white paper details how clinicians and healthcare professionals can work together to improve medical care for all patients.
  • “Social determinants of health affect every person in every society, and their impact on health equity can be positive or negative,” said Sara Champoux, DHSc, PA-C, Vice President of Clinician Value and practicing emergency medicine clinician at Envision Healthcare.
  • The U.S. Department of Health and Human Services’ Office of Disease Prevention and Health Promotion has organized these factors into five domains: